-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
G Guaraldi, C Stentarelli,J Faluz
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
G Guaraldi, C Stentarelli,J Faluz
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
G Guaraldi, C Stentarelli,J Faluz
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
G Guaraldi, C Stentarelli,J Faluz
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
G Guaraldi, C Stentarelli,J Faluz
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
G Guaraldi, C Stentarelli,J Faluz
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
G Guaraldi, C Stentarelli,J Faluz
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
G Guaraldi, C Stentarelli,J Faluz
Review: Clinical Trail Outcomes: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Study suggests that socioeconomic status may affect clinical trial participation
Unger JM, Hershman DL, Albain KS
News and Views: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation